CN1309406C - Medicinal preparation for treating rheumatism and rheumatoid diseases - Google Patents

Medicinal preparation for treating rheumatism and rheumatoid diseases Download PDF

Info

Publication number
CN1309406C
CN1309406C CNB2005100165861A CN200510016586A CN1309406C CN 1309406 C CN1309406 C CN 1309406C CN B2005100165861 A CNB2005100165861 A CN B2005100165861A CN 200510016586 A CN200510016586 A CN 200510016586A CN 1309406 C CN1309406 C CN 1309406C
Authority
CN
China
Prior art keywords
medicinal preparation
medicine
treatment
treating rheumatism
rheumatoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100165861A
Other languages
Chinese (zh)
Other versions
CN1682990A (en
Inventor
刘敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005100165861A priority Critical patent/CN1309406C/en
Publication of CN1682990A publication Critical patent/CN1682990A/en
Application granted granted Critical
Publication of CN1309406C publication Critical patent/CN1309406C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses a medicinal preparation for treating rheumatism and rheumatoid diseases. The medicinal preparation is prepared by using radix aconiti, wild aconite, rhizoma arisaematis, pinellia tuber, frankincense, myrrh, bombyx batryticatus, periostracum cicadae, schizonepeta, pangolin, red peony root, angelica and safflower as raw materials through a scientific processing technology. The medicinal preparation is used for treating rheumatism, rheumatoid arthritis, cervical spondylosis, shoulder periarthritis, lumbar intervertebral disc protrusion, sciatica, hyperosteogeny, etc. Because the medicine is prepared from pure Chinese herbal medicine, the medicinal preparation has little toxic and side effect, and treats both the manifestation causes and the root causes of a disease. The plaster preparation is convenient to apply, has conspicuous curative effect, and has no rebounding phenomenon after healing. Besides, clinical symptoms can rapidly disappear.

Description

A kind of pharmaceutical preparation for the treatment of rheumatic and rheumatoid diseases
Technical field:
The present invention relates to the medicine of rheumatism, rheumatoid disease, say it is to disclose a kind of pharmaceutical preparation for the treatment of rheumatic and rheumatoid diseases definitely, belong to the Chinese medicine technical field.
Background technology:
Rheumatism, the rheumatoid disease traditional Chinese medical science are commonly called as " arthromyodynia " and seriously perplex human beings'health.This disease is many to cause blood vessels obstructed because of wind and cold, damp, numbness resistance blood vessels, shows as muscle muscles and bones joint aches, numb, swelling, even red and swollen distortion, and weight person can cause the destruction of joint sclerotin, causes joint deformity, can't take care of oneself.In the Drug therapy process, the problem that runs into is: the state of an illness twines stupid, and Jing Jiu Bu More makes pathogen go deep into muscles and bones, and coagulation of QI-blood is not all right, and it is turbid to become the living phlegm-damp stasis of blood, and the meridians obturation is obstructed, and these product of non-vegetation can be led to, and must borrow worm Serpentis and so on search to pick and penetrate, and can open and coagulate.Medicine commonly used " controlling numbness looses ", " indometacin " etc., but easily recur after all existing drug withdrawal to some extent, grow and can lead to complications the course of treatment, and have than serious adverse.
Summary of the invention:
The present invention discloses a kind of pharmaceutical preparation for the treatment of rheumatic and rheumatoid diseases, have evident in efficacy, treating both the principal and secondary aspects of a disease characteristics, and cure the no rebound phenomena in back.
Technical solution of the present invention is as follows: according to pathogeny and the Therapeutic Principle of Chinese medicine to rheumatism, rheumatoid disease, with reference to the modern medicine achievement, in the medical treasure-house of motherland, choose and have wind-expelling and dispelling dampness, activating blood circulation to dissipate blood stasis, the pure Chinese herb medicine of anti-inflammatory analgetic is made Chinese medicine preparation through science.
The present invention is made of by weight following medicine:
Radix Aconiti 50-80, Radix Aconiti Kusnezoffii 50-80, Rhizoma Arisaematis 40-55, Rhizoma Pinelliae 40-55, Olibanum 50-60, Myrrha 50-60, Bombyx Batryticatus 30-40, Periostracum Cicadae 30-40, Herba Schizonepetae 25-30, Squama Manis 25-30, Radix Paeoniae Rubra 20-30, Radix Angelicae Sinensis 20-30, Flos Carthami 30-40;
Adopt traditional plaster production technology to make the plaster preparation;
Above-mentioned prescription of the present invention also can be made into other dosage forms pharmaceutically.
Whenever force on and contain crude drug: 30~55 grams.
Using method: directly stick on disease sites.
Be hot product with Radix Aconiti, Radix Aconiti Kusnezoffii among the present invention,, have expelling wind and removing dampness, temperature three-way meridian effect and analgesic effect as monarch drug; Rhizoma Arisaematis, Rhizoma Pinelliae drying dampness to eliminate phlegm to remove the phlegm-damp in the meridians, also have the pain relieving effect, with being ministerial drug; Assistant Olibanum, Myrrha promoting flow of QI and blood to change the blood stasis in the network, make the QI and blood smoothness; Pleasant impression medicines such as Bombyx Batryticatus, Periostracum Cicadae, Herba Schizonepetae, Squama Manis, Radix Paeoniae Rubra, Radix Angelicae Sinensis, Flos Carthami close and use it, and then turbid, the blood stasis of wind-cold damp pathogen and expectorant all can be dispeled, and makes meridians be led to it, and all diseases can be healed.
Characteristics of the present invention are: pure Chinese herbal medicine is made, toxic and side effects is little, treating both the principal and secondary aspects of a disease, evident in efficacy, clinical symptom disappearance is rapid, cure the no rebound phenomena in back, be adapted to the treatment of various rheumatic and rheumatoid arthritis aches, cervical spondylosis, scapulohumeral periarthritis, prolapse of lumbar intervertebral disc, sciatica, hyperosteogeny diseases.
For showing the therapeutic effect of medicine of the present invention, through system's clinical observation: selected case history is divided into 2 groups at random, treatment group (A group) 147 examples, and male's 63 examples, the women 84; Age 19-68 year, average 51 years old; Rheumatic arthritis 49 examples wherein, rheumatoid arthritis 62 examples, other (as cervical spondylosis, scapulohumeral periarthritis, prolapse of lumbar intervertebral disc, sciatica, hyperosteogeny etc.) 36 examples.Matched group 128 examples are male's 59 examples wherein, and the women 69; Age 18-65 year, 48 years old mean age, rheumatic arthritis 36 examples wherein, rheumatoid arthritis 62 examples, other (as cervical spondylosis, scapulohumeral periarthritis, prolapse of lumbar intervertebral disc, sciatica, hyperosteogeny etc.) 30 examples.2 groups of cases are checked through t at aspects such as age, sex, the courses of disease, and difference does not have the significance meaning.Wherein smelting treatment group selects for use ointment of the present invention to stick, and matched group is selected " the deep ball of Jin wind " of vegetable garden board for use.
Criterion of therapeutical effect: (diagnostic criteria) carried out with reference to " the clinical research guideline of new Chinese medicine treatment numbness disease ".
Clinical cure: symptom all disappears, and it is normal that functional activity recovers; Main doctor trained in Western medicine physico-chemical examination is normal.
Produce effects: symptomatology disappears or main disease is eliminated, and function of joint is recovered substantially, can participate in normal work or physical labor; The physico-chemical examination index is normal substantially.
Effectively: cardinal symptom disappears substantially, and main function of joint is recovered substantially or had made marked progress, and can't take care of oneself transfers to and can take care of oneself, or loses the job and work and can state recover to some extent; Main physical and chemical index makes moderate progress.
Invalid: with the treatment before compare, each side does not all have progress.
Therapeutic outcome:
147 examples are organized in clinical total effects treatment, clinical cure 68 examples (46.3%), produce effects 42 examples (%28.6), effective 21 examples (14.3), invalid 16 examples (10.8), total effective rate 89.2%.Matched group 128 examples, clinical cure 31 examples (24.2%), produce effects 26 examples (20.3%), effective 19 examples (14.8%), invalid 52 examples (40.7%), total effective rate 59.3%.Two groups relatively, and the treatment group significantly is better than matched group.See the following form:
Group Clinical cure Produce effects Effectively Invalid Total effective rate (%)
Treatment group 147 68(46.3) 42(28.6) 21(14.3) 16(10.8) 89.2
Matched group 128 31(24.2) 26(20.3) 19(14.8) 52(40.7) 59.3
Case 1
Zhang, sex: man, age: 55 years old;
The main suit: breath rheumatoid 30 years, moist ill because of being subjected in one's early years, weight when light during the state of an illness was once sought medical advice in inside and outside the province how tame hospital, and poor effect, the state of an illness but increase the weight of so far day by day, can't take care of oneself.
Symptom: duplex can not stretch two wrist moderates tetanic (the light activity degree is arranged), both shoulders pain, both arms can not go up act, two hip, two swelling and pain in knee, can not squat down, two ankle swells and ache, can only move and walk.
Chemical examination: RF (+) ESR:85mm/h resists " 0 ":<500u
Diagnosis: rheumatoid arthritis, functional classification IV;
Adopt medical ointment plaster applying treatment of the present invention, through three courses of treatment, two wrists, duplex, both shoulders activity freely, two knee joints can be squatted down, the disappearance of swelling and ache is advised it to continue to stick ointment of the present invention and is consolidated two courses of treatment, follows up a case by regular visits to so far recurrence.
Case 2:
Record certain, sex: woman, age: 42 years old;
The main suit: because of puerperal careless, suffered from rheumatoid 12 years, the state of an illness is very serious, shows effect repeatedly by the multi-treatment state of an illness, causes and can't work.
Symptom: left finesse feels pain, gradually swelling, the distortion of left hand middle finger is at local hospital admission, the chemical examination rheumatoid factor positive, erythrocyte sedimentation rate 90mm/n, anti-" 0 ":<480u begins with the treatment of Western medicine diclofenac, the state of an illness alleviates often bounce-back of back, after use Chinese herbal medicine decoction treatment instead, but poor effect, low thermal phenomenon is persistent.
Use this patent medical ointment plaster applying treatment after course of treatment the left finesse pain disappear, swelling is progressively gone down, it is normal that the distortion of left hand middle finger slowly recovers, and follows the doctor's advice to return to one's perfect health after continuing to use ointment to stick two courses of treatment, and return to duty, follows up a case by regular visits to so far recurrence.
The specific embodiment:
Embodiment 1
Take by weighing raw material by following proportioning: Radix Aconiti 50g, Radix Aconiti Kusnezoffii 58g, Rhizoma Arisaematis 55g, Rhizoma Pinelliae 45g, Olibanum 50g, Myrrha 50g, Bombyx Batryticatus 30g, Periostracum Cicadae 30g, Herba Schizonepetae 25g, Squama Manis 30g, Radix Paeoniae Rubra 20g, Radix Angelicae Sinensis 25g, Flos Carthami 30g, the said medicine pulverize separately is become 80~110 order fine powders, behind the mix homogeneously, putting into 2.5 times of volume Adeps Sus domesticas or Oleum sesami soaked 3-8 days, mild and heavy respiration decocts, the oil temperature control is at 200-320 ℃, and is fried shrivelled to medicine, pulls medicinal residues out, medicine oil is standby.
Medicine oil is heated to more than 320 ℃, when dripping the beading attitude, Colophonium, the white beeswax adding of fusing, stop heating, be sprinkled into the Plumbum preparatium fine powder while hot, constantly stir, make it be fused into paste, pour in the cold water with the thread shape immediately, stir and make its one-tenth ribbon shape, continue to stir, after to be cooled the condensing, pull out and remove moisture, to remove the composition of ointment moderate stimulation skin, be heated to fusing again, take out to share and make the plaster preparation on ground paper and cloth, 35~55g medicine is subsides.
Embodiment 2
Take by weighing raw material by following proportioning: Radix Aconiti 70g, Radix Aconiti Kusnezoffii 80g, Rhizoma Arisaematis 50g, Rhizoma Pinelliae 55g, Olibanum 50g, Myrrha 50g, Bombyx Batryticatus 35g, Periostracum Cicadae 30g, Herba Schizonepetae 30g, Squama Manis 30g, Radix Paeoniae Rubra 25g, Radix Angelicae Sinensis 25g, Flos Carthami 35g, the said medicine pulverize separately is become 100 order fine powders, behind the mix homogeneously, Adeps Sus domestica or the Oleum sesami of putting into 5.0 times of volumes soaked 8 days, mild and heavy respiration decocts, the oil temperature control is at 200-320 ℃, and is fried shrivelled to medicine, pulls medicinal residues out, medicine oil is standby.
Medicine oil is heated to more than 320 ℃, when dripping the beading attitude, Colophonium, the white beeswax adding of fusing, stop heating, be sprinkled into the Plumbum preparatium fine powder while hot, constantly stir, make it be fused into paste, pour in the cold water with the thread shape immediately, stir and make its one-tenth ribbon shape, continue to stir, after to be cooled the condensing, pull out and remove moisture, to remove the composition of ointment moderate stimulation skin, be heated to fusing again, take out to share and make the plaster preparation on ground paper and cloth, 35~55g medicine is subsides.

Claims (2)

1, a kind of drug agents for the treatment of rheumatic and rheumatoid diseases, wherein make raw materials of effective components medicine and weight proportion thereof and be:
Radix Aconiti 50-80, Radix Aconiti Kusnezoffii 50-80, Rhizoma Arisaematis 40-55, Rhizoma Pinelliae 40-55, Olibanum 50-60,
Myrrha 50-60, Bombyx Batryticatus 30-40, Periostracum Cicadae 30-40, Herba Schizonepetae 25-30, Squama Manis 25-30,
Radix Paeoniae Rubra 20-30, Radix Angelicae Sinensis 20-30, Flos Carthami 30-40.
2,, it is characterized in that it is the plaster dosage form according to the drug agents of the described treatment rheumatic and rheumatoid diseases of claim 1.
CNB2005100165861A 2005-02-22 2005-02-22 Medicinal preparation for treating rheumatism and rheumatoid diseases Expired - Fee Related CN1309406C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100165861A CN1309406C (en) 2005-02-22 2005-02-22 Medicinal preparation for treating rheumatism and rheumatoid diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100165861A CN1309406C (en) 2005-02-22 2005-02-22 Medicinal preparation for treating rheumatism and rheumatoid diseases

Publications (2)

Publication Number Publication Date
CN1682990A CN1682990A (en) 2005-10-19
CN1309406C true CN1309406C (en) 2007-04-11

Family

ID=35262609

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100165861A Expired - Fee Related CN1309406C (en) 2005-02-22 2005-02-22 Medicinal preparation for treating rheumatism and rheumatoid diseases

Country Status (1)

Country Link
CN (1) CN1309406C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101721484B (en) * 2009-12-21 2012-01-11 宋栓牛 Traditional Chinese medicine externally-applied agent for treating gonarthromeningitis and preparation method thereof
CN101972464B (en) * 2010-10-29 2011-12-14 韩世昌 Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN102614431B (en) * 2012-04-21 2013-10-23 韩合旭 Medicament for treating gout and bone disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1295841A (en) * 2000-09-01 2001-05-23 李东亚 Adhesive plaster for osteophytosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1295841A (en) * 2000-09-01 2001-05-23 李东亚 Adhesive plaster for osteophytosis

Also Published As

Publication number Publication date
CN1682990A (en) 2005-10-19

Similar Documents

Publication Publication Date Title
CN101411802B (en) Black plaster for treating hyperosteogeny and preparation method thereof
CN102872442B (en) Traditional Chinese medicine capsule for treating scapulohumeral periarthritis
CN1342462A (en) Composite medicine for treating rheumatoid arthritis
CN1309406C (en) Medicinal preparation for treating rheumatism and rheumatoid diseases
CN102872282B (en) Han Shi Bi Ting Wan for treating ankylosing spondylitis
CN1814245A (en) Chinese medicine remedy for treating cervical vertebra disease
CN1739700A (en) Rheumatism treating plaster and its prepn
CN101884777B (en) Chinese medicinal iron applying bag for treating rheumatic osteoarthrosis and preparation method thereof
CN101002848B (en) Medicine for treating recurrent uarthritis, and its preparing method
CN1843421A (en) Rheumatoid disease treating medicine
CN1201765C (en) Chinese medicine ointment for treating arthrosis
CN101518631B (en) Medicament for treating rheumatoid arthritis
CN1140274C (en) Gu'anning ointment for treating hyperosteogeny and its prepn. method
CN1151814C (en) Composite Chinese medicine for treating rheumatic Bi syndrome
CN103735647A (en) Medicated wine for treating chronic infectious arthritis
CN103142794A (en) Paste for drawing out pus to remove sore
CN102813746B (en) Traditional Chinese medicine composition for treating numbness of fingers
CN1695697A (en) Medication for treating ache of rheumatoid arthritis
CN1241580C (en) Medicinal composition for treating hypersteogeny
CN103316133B (en) Medicine for treating lame impediment
CN101623460B (en) Medicine for treating rheumatic pain and preparation method thereof
CN102755487A (en) Traditional Chinese medicine powder for eliminating dampness and invigorating blood circulation
CN106420999A (en) Blood-activating decoction for treating joint degenerative changes
CN1181835C (en) Chinese medicine preparation for treating rheumatism and rheumatoid disease
CN1422639A (en) Dral medicine for treating rheumatism and atrophic diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070411

Termination date: 20100222